$GDRX News

3 Reasons to Avoid GDRX and 1 Stock to Buy Instead

Full Transcript: GoodRx Holdings Q2 2026 Earnings Call

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

Barclays Maintains Underweight on GoodRx Holdings, Raises Price Target to $4

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)

UBS Maintains Neutral on GoodRx Holdings, Raises Price Target to $3.75

GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook

GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise

GoodRx (GDRX) Q2 2026 Earnings Call Transcript

Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5

GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook

TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $5

GoodRx subscription revenue surges 39% as company expands beyond prescriptions

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

GoodRx Q2 Earnings Call Highlights

GoodRx Holdings, Inc. Q2 2026 Earnings Call Summary

GoodRx (NASDAQ:GDRX) Q2 2026: Subscription and Pharma Direct Growth Lift Shares Despite Revenue Decline

GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars

GoodRx Reports Second Quarter 2026 Results